Table.
Characteristics and timing of treatment for 17 health-care workers with SARS
Age (years)/sex/occupation | Protection used | SARS category | Ribavirin started* | Steroid started† | Minipulse started‡ | ICU stay | Maximum oxygen demand | Discharge | |
---|---|---|---|---|---|---|---|---|---|
Patient number | |||||||||
1 | 33/M/doctor | N95 mask | Probable | D1 | D7 | – | No | Room air | D24 |
2 | 28/F/nurse | N95 mask | Suspected | D2 | – | – | No | Room air | D18 |
3 | 26/F/nurse | N95 mask | Probable | D3 | D9 | – | No | Room air | D28 |
4 | 45/F/nurse | N95 mask | Probable | D3 | D10 | – | No | Nasal cannula 3 L/min | D27 |
5 | 26/F/nurse | N95 mask | Probable | D2 | D8 | D13 | No | Nasal cannula 2 L/min | D28 |
6 | 49/F/register | Surgical mask | Probable | D2 | D6 | D15 | Yes | Intubated with FiO2 0·6 | D52 |
7 | 51/F/porter | Surgical mask | Probable | D7 | D13 | – | No | Nasal cannula 3 L/min | D33 |
8 | 49/F/porter | Surgical mask | Probable | D4 | D7 | – | No | Nasal cannula 3 L/min | D25 |
9 | 34/M/doctor | N95 mask | Suspected | D6 | – | – | No | Room air | D6 |
10 | 53/F/doctor | N95 mask | Suspected | D2 | – | – | No | Room air | D14 |
11 | 41/F/nurse | N95 mask | Probable | D1 | D10 | – | No | Room air | D20 |
12 | 27/F/nurse | N95 mask | Suspected | D4 | – | – | No | Room air | D10 |
13 | 35/F/nurse | N95 mask | Probable | D2 | D9 | – | No | Room air | D20 |
14 | 28/F/nurse | N95 mask | Suspected | D3 | – | – | No | Room air | D12 |
15 | 30/F/doctor | N95 mask | Probable | D2 | D8 | – | No | Room air | D26 |
16 | 42/M/technician | N95 mask | Probable | D2 | D11 | – | No | Nasal cannula 3 L/min | D29 |
17 | 57/F/porter | N95 mask | Probable | D3 | D13 | – | No | Room air | D23 |
F=female. M=male. D=day since onset of fever. ICU=intensive care unit; FiO2=fractional concentration of oxygen in inspired gas.
Oral ribavirin 2000 mg loading then 600 mg twice daily.
Intravenous methylprednisolone 2 mg/kg daily.
Intravenous methylprednisolone 500 mg daily.